Department of Pediatric Nephrology, Children's Hospital, Friedrich Schiller University, Jena, Germany.
Pediatr Nephrol. 2012 Mar;27(3):443-50. doi: 10.1007/s00467-011-1999-2. Epub 2011 Oct 19.
Posterior urethral valves (PUV) associated with renal dysplasia are one of the most common causes of end stage kidney disease (ESKD) in childhood. In order to identify risk factors for the progression of this condition to early renal failure, we have retrospectively analyzed the clinical course, renal function, and first postnatal renal ultrasound in a sample of 42 young male patients with PUV, who were followed at a single center. Twelve (28.6%) were diagnosed with ESKD at a median age of 11.3 years. Our comparison of PUV patients without decreased estimated glomerular filtration rate (eGFR) (group A; K/DOQI CKD stage 0-1) with PUV patients showing a decreased eGFR (group B; K/DOQI CKD stage 2-5) revealed the following significant risk factors for loss of eGFR: renal volume <3rd percentile (P < 0.001), elevated echogenicity (P = 0.001), pathologic corticomedullary differentiation (P < 0.001), >3 febrile urinary tract infections (P = 0.012), and decreased eGFR at 1 year of age (P < 0.001). Receiver operating characteristic curve analysis in the cohort confirms that patients showing a renal volume >88.2 ml/m(2) body surface area (BSA) are not at risk to develop K/DOQI CKD stage 5 (sensitivity 75%, specificity 77.3%, positive/negative predictive value 37.5/94.4%). Ultrasound promises to be a valuable tool for identifying endangered patients.
后尿道瓣膜(PUV)合并肾发育不良是儿童终末期肾病(ESKD)的最常见原因之一。为了确定这种情况进展为早期肾衰竭的危险因素,我们对在单中心接受随访的 42 名男性 PUV 年轻患者的临床病程、肾功能和首次产后肾脏超声进行了回顾性分析。12 名(28.6%)患者在中位数为 11.3 岁时被诊断为 ESKD。我们比较了肾小球滤过率估计值(eGFR)未降低的 PUV 患者(组 A;K/DOQI CKD 分期 0-1)与 eGFR 降低的 PUV 患者(组 B;K/DOQI CKD 分期 2-5),发现 eGFR 丧失的以下显著危险因素:肾脏体积<第 3 百分位数(P<0.001)、回声增强(P=0.001)、病理性皮质髓质分化(P<0.001)、>3 次发热性尿路感染(P=0.012)和 1 岁时 eGFR 降低(P<0.001)。队列中的受试者工作特征曲线分析证实,肾脏体积>88.2ml/m2体表面积(BSA)的患者不会有进展为 K/DOQI CKD 分期 5 的风险(敏感性 75%,特异性 77.3%,阳性/阴性预测值分别为 37.5%和 94.4%)。超声有望成为识别高危患者的有价值工具。